Page 5 - தலை ஆஃப் உலகளாவிய பெருநிறுவன தகவல்தொடர்புகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தலை ஆஃப் உலகளாவிய பெருநிறுவன தகவல்தொடர்புகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தலை ஆஃப் உலகளாவிய பெருநிறுவன தகவல்தொடர்புகள் Today - Breaking & Trending Today

CSRWire - Addressing Our Accountability in Creating a More Equitable and Diverse Tech Sector


Addressing Our Accountability in Creating a More Equitable and Diverse Tech Sector
Addressing Our Accountability in Creating a More Equitable and Diverse Tech Sector
Seeing this level of commitment and passion from NortonLifeLock leadership was energizing and I’m excited about the opportunities ahead of us.
Published 03-05-21
By Spring Harris, Head of Global Corporate Communications and Public Relations
On January 20, 2021, I had the pleasure of hosting Dwana Franklin-Davis, CEO of Reboot Representation, for a company-wide presentation and fireside chat with NortonLifeLock’s CEO Vincent Pilette and Head of People and Culture Kara Jordan on creating a more equitable and diverse tech sector. ....

United States , Dwana Franklin Davis , Vincent Pilette , Kamala Harris , Head Of Global Corporate Communications , Spring Harris , Global Corporate Communications , Reboot Representation , Culture Kara Jordan , Vice President , South Asian , Black Life Empowerment , ஒன்றுபட்டது மாநிலங்களில் , கமலா ஹாரிஸ் , தலை ஆஃப் உலகளாவிய பெருநிறுவன தகவல்தொடர்புகள் , வசந்த ஹாரிஸ் , உலகளாவிய பெருநிறுவன தகவல்தொடர்புகள் , ரிபூவாய்ட் பிரதிநிதித்துவம் , கலாச்சாரம் காரா ஜோர்டான் , துணை ப்ரெஸிடெஂட் , தெற்கு ஆசிய , கருப்பு வாழ்க்கை அதிகாரம் ,

Amicus Therapeutics Announces Positive Initial Clinical Data for CLN3 Batten Disease Gene ...


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Amicus Therapeutics Announces Positive Initial Clinical Data for CLN3 Batten Disease Gene .
Amicus Therapeutics, Inc.February 8, 2021 GMT
Initial Data Suggest Early Signs of Disease Stabilization in Children with
Fatal Neurologic Disease
Plan to Submit IND for Next Clinical Study in 2H2021
PHILADELPHIA, Feb. 08, 2021 (GLOBE NEWSWIRE) Amicus Therapeutics (Nasdaq: FOLD) today announced positive initial results from its first in-human study of its CLN3 Batten disease gene therapy program, AT-GTX-502. The results are featured in a virtual poster presentation at the 17th Annual WORLD
Symposium ™ 2021, being held February 8-12, 2021. The poster is also available in the Events and Presentations section of the Amicus Therapeutics corporate website. ....

United States , Andrew Faughnan , Los Reyes , Diana Moore , Jeff Castelli , Amicus Therapeutics , Abigail Wexner Research Institute , Drug Administration , Head Of Global Corporate Communications , Ohio State University College Of Medicine , Initial Data Suggest Early Signs , Disease Stabilization , Fatal Neurologic , Next Clinical Study , Nationwide Children , Unified Batten Disease Rating Scale , Data Highlights , Batten Disease Rating Scale , Chief Development Officer , Principal Investigator , Clinical Pediatrics , Ohio State University College , Fast Track Designation , Rare Pediatric Designation , United States Food , Orphan Drug ,

Amicus Therapeutics Announces Presentations and Posters at the 17th Annual WORLDSymposium™ 2021


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Amicus Therapeutics Announces Presentations and Posters at the 17th Annual WORLDSymposium™ 2021
Amicus Therapeutics, Inc.January 21, 2021 GMT
CRANBURY, N.J., Jan. 21, 2021 (GLOBE NEWSWIRE) Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on discovering, developing and delivering novel medicines for rare diseases, today announced that three oral presentations and ten posters highlighting its development programs for Lysosomal Disorders will be included at the 17th Annual WORLD
Symposium ™ 2021, to be held virtually February 8-12, 2021.
ADVERTISEMENT
Oral Platform Presentations:
Direct intercellular cross-correction of α-galactosidase-A deficiency in Fabry disease podocytes through tunneling nanotubes in a mixed cell culture model – Behzad Najafian, MD, Department of Pathology, University of Washington, Sea ....

United States , United Kingdom , City Of , Andrew Faughnan , Shelly Goomber , Michaela Ueberall , Diana Moore , Tobias Willer , Uma Ramaswami , Behzad Najafian , John Jefferies , Heathera Lau , Los Reyes , Franklin Johnson , Amicus Therapeutics , Division Of Neurogenetics , Division Of Medical Genetics , Amicus Therapeutics Inc , Copenhagen University Hospital , Duke University Medical Center , University Of Washington , York University , Institute Of Neurological Sciences , Department Of Endocrinology , Division Of Cardiovascular Disease , Head Of Global Corporate Communications ,

IPG Mediabrands Launches "TRAVERSE32," New Independent Development and Entertainment Company


Press release content from Business Wire. The AP news staff was not involved in its creation.
IPG Mediabrands Launches “TRAVERSE32,” New Independent Development and Entertainment Company
December 17, 2020 GMT
NEW YORK (BUSINESS WIRE) Dec 17, 2020
IPG Mediabrands today announced the launch of TRAVERSE32, an independent development and entertainment company aimed at connecting film and television audiences with the world’s most highly influential brands and creators. TRAVERSE32 Co-Founder Brendan Gaul, Mediabrands’ recently appointed first-ever Global Chief Content Officer, will simultaneously serve as its Global President.
ADVERTISEMENT
Henenberg and Gaul at the 2019 NYC premiere of 5B   Courtesy of Getty. Photo Credit: Cindy Ord / Stringer ....

New York , United States , Brett Henenberg , Neena Koyen , Daryl Lee , Christopher Karpenko , Josh Braun , Brendan Gaul , Operation Santa Centers , Orion Holdings , Interpublic Group , Head Of Global Corporate Communications , Cannes International Film Festival , United States Postal Service , Media Lab , Founder Brendan Gaul , Global Chief Content Officer , Photo Credit , Cindy Ord , Global Head , Mediabrands Content Studio , Chief Content Officer , San Sebastian Film Festival , Amazon Prime , Dana Nachman , Chelsea Matter ,